Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective
Abstract
Authors
A Perrin A Chua J Ricci M Neary M Thabane